Original from: Genomeweb
Applied DNA Sciences on Thursday priced a planned $12 million public offering of stock and warrants.
Through the offering, the Stony Brook, New York-based company will offer 3 million shares of its common stock, along with Series A and B warrants to purchase up to 6 million shares of common stock, at $4 per share and associated warrants. Both classes of warrants will be immediately exercisable at $4 apiece.
The offering is expected to close on or around Aug. 8.
Applied DNA, which earlier this year closed a roughly $4.2 million registered direct stock offering, said it will use the proceeds of the public offering to further the development of its therapeutic DNA production and molecular diagnostic testing services, as well as for general corporate purposes.
Copyright © 2025 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.